Some visit links earn us a commission.
Quick verdict
Mochi Health is the better pick for most patients on overall scoring. Flat monthly pricing, transparent compounded sourcing and no lock-in. Best fit for cash-pay patients who want predictable monthly billing.
That said, Medvi wins on specific dimensions. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
Side-by-side
| Mochi Health | Medvi | |
|---|---|---|
| Starts from | $178/mo (incl. medication) | $299/mo (incl. medication) |
| Monthly cost gap | Mochi Health is $1/mo cheaper than Medvi | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 3 days | 2 days |
| Consultation type | Live | Asynchronous |
| Affiliate network | Impact | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Mochi Health | Medvi | |
|---|---|---|
| Pricing transparency | 9/10 | 8/10 |
| Cancellation terms | 9/10 | 8/10 |
| Onboarding experience | 8/10 | 7/10 |
| Medication options | 6/10 | 7/10 |
| Member reviews | 9/10 | 9/10 |
When to choose Mochi Health
Best for flat predictable cash-pay
Cash-pay patients who want predictable monthly pricing and a compounded GLP-1 path.
Mochi Health wins on pricing transparency, cancellation terms, onboarding experience and runs $1/mo cheaper than Medvi at the entry tier ($178 vs $179). Over a year that's $12 you keep. The caveat: Patients who specifically want FDA-approved branded Wegovy or Zepbound through insurance. Note also: Active in Lilly's 2025-2026 lawsuit against compounded tirzepatide pharmacies
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on medication options on the dimensional scoring. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
If cost is your main filter
Mochi Health is the cheaper monthly: $178 all-in vs $179 for Medvi. That's $1 a month or $12a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $3 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Mochi Health (month-to-month) and Medvi (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Mochi Health cheaper than Medvi?
Can I switch from Mochi Health to Medvi mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
